{
    "N/R/U": null,
    "Applicant": "Sandoz Inc.",
    "BLA Number": "761042",
    "Proprietary Name": "Erelzi",
    "Proper Name": "etanercept-szzs",
    "BLA Type": "351(k) Biosimilar",
    "Strength": "25MG",
    "Dosage Form": "For Injection",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Multi-Dose Vial",
    "Marketing Status": "Disc",
    "Licensure": "Licensed",
    "Approval Date": "November 10, 2022",
    "Ref. Product Proper Name": "etanercept",
    "Ref. Product Proprietary Name": "Enbrel",
    "Supplement Number": "18",
    "Submission Type": "Supplement",
    "License Number": "2003",
    "Product Number": "004",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "etanercept-szzs",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00005"
        }
    ]
}